Please find attached the disclosure under Reg 7(2) of the SEBI (Prohibition of Insider Trading) Reg 2015
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 2.0 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sastasundar Ventures Limited informed the stock exchanges that promoter Mr. Banwari Lal Mittal acquired 15,000 equity shares of the company through a market purchase on 19 November 2025. The total consideration for the acquisition was approximately Rs. 47.82 lakh (inclusive of taxes). Post-acquisition, Mr. Mittal's shareholding increased from 1,06,41,000 shares (33.4512%) to 1,06,56,000 shares (33.4983%), a marginal rise of about 0.05 percentage points. The disclosure was filed under the insider trading regulations as a continual disclosure by the promoter. No derivative trades were undertaken as part of this transaction.
This is a minor open-market purchase by the promoter indicating continued confidence in the company, but the size is too small to materially affect shareholding or stock price.